ClinicalTrials.Veeva

Menu

Is the 4MGS a Useful Outcome Measure Post-PPCI

R

Royal Brompton & Harefield NHS Foundation Trust

Status

Completed

Conditions

Acute Myocardial Infarction

Study type

Observational

Funder types

Other

Identifiers

NCT02261324
2013LF001H

Details and patient eligibility

About

This study aims to assess usual walking speed (4-metre gait speed) in patients undergoing primary percutaneous coronary intervention (PCI) for acute myocardial infarction and to assess whether this can predict future cardiovascular events and death.

Enrollment

560 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Any patient hospitalised with an acute myocardial infarction who has undergone primary percutaneous coronary intervention
  • Capacity to consent
  • Able to walk
  • Age over 18 years

Exclusion criteria

  • Significant co-morbidities that would limit exercise capacity or make exercise unsafe (e.g. neuromuscular disease, severe hip/lower limb joint pain, peripheral vascular disease, lower limb amputation)

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems